Latest filing published 27 Nov 2023 for 10x Genomics, Inc., €137k.
Filing timeline
BuySaleInsider track record
James Wilbur: trading record in brief
This profile gathers the share dealings of James Wilbur in 10x Genomics, Inc. In total, 6 filings cover trades dated from 14 September 2022 to 22 November 2023.
On the market, this insider has only sold: 4 sales, €1.1M in total. Besides market trades, the filings include 2 share grants. 2023 to date brings no purchases and 4 sales.
The record was last updated on 27 November 2023 with an open-market sale (€137k) in 10x Genomics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Wilbur
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,464 shares@ US$43.336712.2% of flowClass A Common StockSEC:0001610717-23-000367:0
- 14,718 shares@ US$42.090950.2% of flowClass A Common StockSEC:0001610717-23-000361:0
- 9,699 shares@ US$45.781136.2% of flowClass A Common StockSEC:0001610717-23-000236:0
- 316 shares@ US$55.06531.4% of flowClass A Common StockSEC:0001610717-23-000065:0
- 14,555 shares0Class A Common StockSEC:0001140361-23-013503:0
- 95,839 shares0Class A Common StockSEC:0001567619-22-017561:0
6 of 6 declarations
